Greg Yothers

Research interests

Publications

• Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

  The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)00285-4

• Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.09.159

• Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2105215

• ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

  Nature Reviews Clinical Oncology · 2020 · https://doi.org/10.1038/s41571-020-0392-0

• Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

  JNCI Journal of the National Cancer Institute · 2015 · https://doi.org/10.1093/jnci/djv248

• Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.53.7753

• Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.36.4539

• DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

  JNCI Journal of the National Cancer Institute · 2011 · https://doi.org/10.1093/jnci/djr153

• Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.30.0855

• National Institutes of Health State-of-the-Science Conference Statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009

  JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djp485

• Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.22.0467

• Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.19.5362

• Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.21.9220

• Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.08.2974

• Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa052122

• Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.02.4091

Current projects

No projects listed.